The Role Of Nurse-Led Technology Solutions In Augmenting Patient Monitoring Strategies
Abstract
Telehealth saw significant expansion and was embraced as an alternative for in-person patient and nurse visits during the outbreak of COVID-19. Nevertheless, there is a lack of research on the mapping of nurse-led telehealth interventions during the epidemic. The objective of this research was to identify and provide a concise overview of the advantages and limitations of nurse-led telehealth treatments for outpatients living in the community during the COVID-19 epidemic. This research used a scoping review technique and followed the guidelines provided by the Preferred Reporting Items for Systematic Reviews and Meta-analyses Scoping Review Extension. A systematic search was conducted across five electronic databases to identify papers published in English peer-reviewed journals from January 2020 to February 2022. Out of the 490 publications that were found, 23 empirical studies were chosen according to the inclusion/exclusion criteria. The analysis included primary studies conducted in nine different nations, using a range of research methodologies. The study revealed four advantages and three disadvantages of nurse-led telehealth treatments for patients during the COVID-19 pandemic. In order to ensure that telehealth services provide effective, efficient, and high-quality patient care, future research and nursing practice must address the limitations that have been discovered in present nurse-led telehealth treatments. Enhancing the quality of patient care may be achieved via the implementation of more rigorous evidence-based research and the development of updated and standardized standards for nurses' telehealth services. The results of this scoping assessment may be used by nurse managers, executives, and legislators to enhance the existing telehealth services system.
Metrics
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
CC Attribution-NonCommercial-NoDerivatives 4.0